Evidence map›Paper›PMID 24687495›Full record

ArticleAntimicrobial agents and chemotherapy2014

Antifungal susceptibility patterns of opportunistic fungi in the genera Verruconis and Ochroconis.

S Seyedmousavi, K Samerpitak, A J M M Rijs, W J G Melchers, J W Mouton, P E Verweij, G S de Hoog

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. PulmonaryJournal of fungi (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Article
  5. Answer to July 2023 Photo Quiz.Journal of clinical microbiology · 2023
    Article
  6. Unusual manifestation of pulmonaryBMJ case reports · 2023
    Article
  7. RE-EVALUATION OFPersoonia · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Respiratory medicine case reports · 2017
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 5 countries.

S SeyedmousaviDepartment of Medical Microbiology, Radboudumc, Nijmegen, The Netherlands Invasive Fungi Research Center, Mazandaran University of Medical Sciences, Sari, Iran S.Seyedmousavi@gmail.com.
K SamerpitakDepartment of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand CBS-KNAW Fungal Biodiversity Centre, Utrecht, The Netherlands Institute for Biodiversity and Ecosystem Dynamics, University of Amsterdam, Amsterdam, The Netherlands.
A J M M RijsDepartment of Medical Microbiology, Radboudumc, Nijmegen, The Netherlands.
W J G MelchersDepartment of Medical Microbiology, Radboudumc, Nijmegen, The Netherlands.
J W MoutonDepartment of Medical Microbiology, Radboudumc, Nijmegen, The Netherlands.
P E VerweijDepartment of Medical Microbiology, Radboudumc, Nijmegen, The Netherlands.
G S de HoogCBS-KNAW Fungal Biodiversity Centre, Utrecht, The Netherlands Institute for Biodiversity and Ecosystem Dynamics, University of Amsterdam, Amsterdam, The Netherlands Peking University Health Science Center, Research Center for Medical Mycology, Beijing, China Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China Shanghai Institute of Medical Mycology, Changzheng Hospital, Second Military Medical University, Shanghai, China Basic Pathology Department, Federal University of Paraná State, Curitiba, Paraná, Brazil King Abdullassiz University, Jeddah, Saudi Arabia.
Radboud University Medical Center · NLRadboud University Nijmegen · NLUniversity of Amsterdam · NLMazandaran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Species of Verruconis and species of Ochroconis are dematiaceous fungi generally found in the environment but having the ability to infect humans, dogs, cats, poultry, and fish. This study presents the antifungal susceptibility patterns of these fungi at the species level. Forty strains originating from clinical and environmental sources were phylogenetically identified at the species level by using sequences of the ribosomal DNA internal transcribed spacer (rDNA ITS). In vitro antifungal susceptibility testing was performed against eight antifungals, using the Clinical and Laboratory Standards Institute (CLSI) broth microdilution method. The geometric mean MICs for amphotericin B (AMB), flucytosine (5FC), fluconazole (FLC), itraconazole (ITC), voriconazole (VRC), and posaconazole (POS) and minimum effective concentrations (MECs) for caspofungin (CAS) and anidulafungin (AFG) across the Ochroconis and Verruconis species were as follows, in increasing order. For Verruconis species, the values (μg/ml) were as follows: AFG, 0.04; POS, 0.25; ITC, 0.37; AMB, 0.50; CAS, 0.65; VRC, 0.96; 5FC, 10.45; and FLC, 47.25. For Ochroconis species, the values (μg/ml) were as follows: AFG, 0.06; POS, 0.11; CAS, 0.67; VRC, 2.76; ITC, 3.94; AMB, 5.68; 5FC, 34.48; and FLC, 61.33. Antifungal susceptibility of Ochroconis and Verruconis was linked with phylogenetic distance and thermotolerance. Echinocandins and POS showed the greatest in vitro activity, providing possible treatment options for Ochroconis and Verruconis infections.

Indexed as

Antifungal AgentsAscomycotaDNA, FungalDNA, RibosomalDNA, Ribosomal SpacerMicrobial Sensitivity TestsMitosporic FungiMycosesAntifungal AgentsDNA, FungalDNA, RibosomalDNA, Ribosomal Spacer

Identifiers

PMID24687495
PMCPMC4068420
OpenAlexW2098947476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.